34 results on '"Bianchi, Nicoletta"'
Search Results
2. TumFlow: An AI Model for Predicting New Anticancer Molecules
3. State‐of‐the‐art in transposable element modulation affected by drugs in malignant prostatic cancer cells
4. Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy.
5. Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences
6. Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines
7. Conséquences de la crue extrême du 2 octobre 2020 dans la vallée de la Roya (Alpes Maritimes) sur les réseaux de transport et de communication : leçons pour la reconstruction
8. Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype
9. Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response
10. Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines
11. Characterization by Gene Expression Analysis of Two Groups of Dopaminergic Cells Isolated from the Mouse Olfactory Bulb
12. The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers
13. A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer
14. The inhibition of MDM2 slows cell proliferation and activates apoptosis in ADPKD cell lines
15. New Therapeutic Interventions for Kidney Carcinoma: Looking to the Future
16. Machine Learning Algorithms Highlight tRNA Information Content and Chargaff’s Second Parity Rule Score as Important Features in Discriminating Probiotics from Non-Probiotics
17. Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways.
18. Evaluation of the return time of flash floods generated in the Roya Valley (Alpes Maritime, France) on October 2, 2020: What challenges does this type of event pose for risk management?
19. Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype
20. Circulating microRNAs Suggest Networks Associated with Biological Functions in Aggressive Refractory Type 2 Celiac Disease
21. Detection of disease‐causing mutations in prostate cancer by NGS sequencing
22. A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K + Channel in Breast Cancer.
23. The inhibition of MDM2 slows cell proliferation and activates apoptosis in ADPKD cell lines.
24. Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer
25. Problématiques digestives et nutritionnelles de l’enfant en situation de handicap
26. UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines
27. The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2
28. New Therapeutic Interventions for Kidney Carcinoma: Looking to the Future.
29. Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells.
30. The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma.
31. Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways
32. Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer.
33. A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K + Channel in Breast Cancer.
34. [Digestive and nutritional problems of children with cerebral palsy].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.